<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <!--The publisher of this article does not allow downloading of the full text in XML form.-->
  <?properties manuscript?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-journal-id">9100095</journal-id>
      <journal-id journal-id-type="pubmed-jr-id">8509</journal-id>
      <journal-id journal-id-type="nlm-ta">Mol Cell Neurosci</journal-id>
      <journal-id journal-id-type="iso-abbrev">Mol. Cell. Neurosci.</journal-id>
      <journal-title-group>
        <journal-title>Molecular and cellular neurosciences</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1044-7431</issn>
      <issn pub-type="epub">1095-9327</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26546150</article-id>
      <article-id pub-id-type="pmc">4698043</article-id>
      <article-id pub-id-type="doi">10.1016/j.mcn.2015.11.002</article-id>
      <article-id pub-id-type="manuscript">NIHMS738555</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Intracellular LINGO-1 Negatively Regulates Trk Neurotrophin Receptor Signaling</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Meabon</surname>
            <given-names>James S.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Laat</surname>
            <given-names>Rian</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ieguchi</surname>
            <given-names>Katsuaki</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Serbzhinsky</surname>
            <given-names>Dmitry</given-names>
          </name>
          <xref ref-type="aff" rid="A5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hudson</surname>
            <given-names>Mark P.</given-names>
          </name>
          <xref ref-type="aff" rid="A6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Huber</surname>
            <given-names>B. Russel</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wiley</surname>
            <given-names>Jesse C.</given-names>
          </name>
          <xref ref-type="aff" rid="A7">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bothwell</surname>
            <given-names>Mark</given-names>
          </name>
          <xref ref-type="aff" rid="A6">6</xref>
          <xref rid="FN1" ref-type="author-notes">*</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA 98195</aff>
      <aff id="A2"><label>2</label>Mental Illness Research Education and Clinical Center, VA Medical Center, Seattle, WA 98108</aff>
      <aff id="A3"><label>3</label>Immusoft, Seattle, WA 98103</aff>
      <aff id="A4"><label>4</label>Department of Pharmacology, Tokyo Women&#x2019;s Medical University, Tokyo, Japan</aff>
      <aff id="A5"><label>5</label>Seattle Biomedical Research Institute, Seattle, WA 98109</aff>
      <aff id="A6"><label>6</label>Department of Physiology &amp; Biophysics, University of Washington, Seattle, WA 98195</aff>
      <aff id="A7"><label>7</label>Department of Comparative Medicine, University of Washington, Seattle, WA 98195</aff>
      <author-notes>
        <corresp id="FN1"><label>*</label>Corresponding Author: Mark Bothwell, Ph.D., University of Washington, Dept. of Physiology &amp; Biophysics, Institute for Stem Cell and Regenerative Medicine, 850 Republican St., Seattle, WA 98109, U.S.A. Tel: +1-206-543-7924, Fax: +1-206-685-0619, <email>mab@u.washington.edu</email></corresp>
      </author-notes>
      <pub-date pub-type="nihms-submitted">
        <day>26</day>
        <month>11</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>03</day>
        <month>11</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>01</day>
        <month>1</month>
        <year>2017</year>
      </pub-date>
      <volume>70</volume>
      <fpage>1</fpage>
      <lpage>10</lpage>
      <!--elocation-id from pubmed: 10.1016/j.mcn.2015.11.002-->
      <abstract>
        <p id="P2">Neurotrophins, essential regulators of many aspects of neuronal differentiation and function, signal via four receptors, p75, TrkA, TrkB and TrkC. The three Trk paralogs are members of the LIG superfamily of membrane proteins, which share extracellular domains consisting of leucine rich repeat and C2 Ig domains. Another LIG protein, LINGO-1 has been reported to bind and influence signaling of p75 as well as TrkA, TrkB and TrkC. Here we examine the manner in which LINGO-1 influences the function of TrkA, TrkB and TrkC. We report that Trk activation promotes Trk association with LINGO-1, and that this association promotes Trk degradation by a lysosomal mechanism. This mechanism resembles the mechanism by which another LIG protein, LRIG1, promotes lysosomal degradation of receptor tyrosine kinases such as the EGF receptor. We present evidence indicating that the Trk/LINGO-1 interaction occurs, in part, within recycling endosomes. We show that a mutant form of LINGO-1, with much of the extracellular domain deleted, has the capacity to enhance TrkA signaling in PC12 cells, possibly by acting as an inhibitor of Trk down-regulation by full length LINGO-1. We propose that LINGO-1 functions as a negative feedback regulator of signaling by cognate receptor tyrosine kinases including TrkA, TrkB and TrkC.</p>
      </abstract>
      <kwd-group>
        <kwd>LINGO-1</kwd>
        <kwd>LRRN6a</kwd>
        <kwd>TrkA</kwd>
        <kwd>TrkB</kwd>
        <kwd>TrkC</kwd>
        <kwd>LINX</kwd>
      </kwd-group>
    </article-meta>
  </front>
</article>
</pmc-articleset>